Wow, we’ve just received an award from Feedspot, for being one of the top COPD blogs on the planet. We were ranked on the following criteria: Google reputation and Google search ranking Influence and popularity on Facebook, twitter and other social media sites Quality and consistency of posts. Feedspot’s editorial team and expert review HaveContinue reading “Award for being one of the top 25 COPD blogs on the planet”
Author Archives: CarolCT
Managing elderly patients with COPD through empowerment
Demographic, familial, and social factors have important roles in the process of empowering elderly patients with chronic obstructive pulmonary disease (COPD), according to a study published in PLoS One. For elderly patients with COPD, empowerment techniques are central to reducing the severity or frequency of exacerbations, preventing hospitalization, and improving health-related quality of life. ZahraContinue reading “Managing elderly patients with COPD through empowerment”
Real-World Observational Study Will Aid in Understanding of Progression of COPD
A new collaboration between the Duke Clinical Research Institute, Duke University’s MURDOCK Study, and Boehringer Ingelheim Pharmaceuticals Inc will try to better understand how chronic obstructive pulmonary disease progresses in the real world. See more at: http://www.ajmc.com/newsroom/real-world-observational-study-will-aid-in-understanding-of-progression-of-copd#sthash.BQsjE9Ti.dpuf
“What are my chances of developing COPD if one of my parents has the disease?”
“What are my chances of developing COPD if one of my parents has the disease?” A systematic review and meta-analysis of prevalence of co-occurrence of COPD diagnosis in parents and offspring Authors Li LSK, Paquet C, Johnston K, Williams MT Published International Journal of Chronic Obstructive Pulmonary Disease 24 January 2017 Volume 2017:12 Pages 403—415Continue reading ““What are my chances of developing COPD if one of my parents has the disease?””
COPD study shows misdiagnosis common
According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the diagnosis of COPD in any patient who has a history of chronic cough, sputum production, difficulty breathing, or exposure to risk factors. A study conducted at the CorpusContinue reading “COPD study shows misdiagnosis common”
Study Predicts COPD Epidemic in 20 Years, Potentially Overwhelming Healthcare Systems
Abstract COPD is currently one of the leading causes of hospitalizations in industrialized countries. The future burden of COPD is uncertain as the trends in the prevalence of the main risk factors for COPD, namely cigarette smoking and population aging, are moving in opposite directions in many jurisdictions. Here, we used data from British ColumbiaContinue reading “Study Predicts COPD Epidemic in 20 Years, Potentially Overwhelming Healthcare Systems”
The disease burden of chronic obstructive pulmonary disease in Greece
This survey provides insightful data regarding the impact of COPD on Greek patients’ everyday life, psychology, and productivity, revealing the increased individual morbidity and the significant burden of this condition on society. International Journal of Chronic Obstructive Pulmonary Disease, 2016 Volume 2016:11(1) Pages 2179—2189 Authors Kourlaba G, Hillas G, Vassilakopoulos T, Maniadakis N Background: The objectiveContinue reading “The disease burden of chronic obstructive pulmonary disease in Greece”
Triple-combination therapy reduces COPD exacerbations
GlaxoSmithKline and Innoviva’s triple-combination therapy of fluticasone furoate, umeclidinium and vilanterol significantly reduced the amount of exacerbations experienced by patients with chronic obstructive pulmonary disease compared with AstraZeneca’s Symbicort Turbohaler, according to phase 3 study results presented at the 2016 European Respiratory Society International Congress. Results showed that patients in the triple-combination therapy group hadContinue reading “Triple-combination therapy reduces COPD exacerbations”
Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice
Guidelines on the management of chronic obstructive pulmonary disease (COPD) are based on numerous randomized, controlled trials of efficacy, which are usually generated for registration purposes. However, these trials have included patients who were selected with the use of strict criteria and were closely monitored, and therefore the results have limited relevance to everyday clinicalContinue reading “Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice”
Pulmonary rehabilitation as a mechanism to reduce hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis
Abstract Background Acute exacerbations of COPD (AECOPD) have a significant impact on healthcare utilization, including physician visits and hospitalizations. Previous studies and reviews have shown that pulmonary rehabilitation has many benefits but the effect on hospitalizations for AECOPD is inconclusive. Methods A literature search was carried out to find studies that might help determine, usingContinue reading “Pulmonary rehabilitation as a mechanism to reduce hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis”
Don't Forget To Breathe 